Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of adefovir dipivoxil for
the treatment of chronic hepatitis B in children and adolescents (age 2 to less than 18
years) following 48 weeks of placebo-controlled, double-blind treatment and following an
additional 192 weeks of open-label adefovir dipivoxil treatment.